- Home
- WMB vs GSK Comparison
WMB vs GSK Comparison
Compare WMB & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WMB | GSK |
|---|---|---|
| Founded | 1908 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6B | 108.7B |
| IPO Year | 2002 | 2013 |
Fundamental Metrics
Financial Performance| Metric | WMB | GSK |
|---|---|---|
| Price | $70.87 | $52.52 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 2 |
| Target Price | ★ $77.41 | N/A |
| AVG Volume (30 Days) | ★ 6.0M | 4.0M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | 2.86% | ★ 3.40% |
| EPS Growth | ★ 17.58 | N/A |
| EPS | ★ 1.38 | N/A |
| Revenue | ★ $11,950,000,000.00 | N/A |
| Revenue This Year | $6.97 | $6.99 |
| Revenue Next Year | $9.85 | $4.19 |
| P/E Ratio | $52.09 | ★ $32.75 |
| Revenue Growth | ★ 13.78 | N/A |
| 52 Week Low | $56.09 | $38.63 |
| 52 Week High | $80.08 | $61.70 |
Technical Indicators
Market Signals| Indicator | WMB | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 43.09 | 54.12 |
| Support Level | $69.47 | $49.92 |
| Resistance Level | $75.75 | $53.61 |
| Average True Range (ATR) | 2.06 | 0.83 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 30.46 | 84.14 |
Price Performance
Historical ComparisonAbout WMB Williams Companies Inc. (The)
Williams operates the Transco pipeline, which connects the Gulf Coast to the Northeast United States. It has additional natural gas transmission pipelines connecting the Rockies to the Pacific Northwest and midcontinent. At the field level, it operates substantial gathering and processing assets in Appalachia and other basins. The company has also struck several power supply agreements.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.